Counterregulatory Actions of Angiotensin-(1-7)

Hypertension

Volumn 30, Issue 3, 1997, Pages 535-541

  Ferrario, Carlos M ^a   Chappell, Mark C ^a   Tallant, E Ann ^a   Brosnihan, K Bridget ^a   Diz, Debra I ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ALDOSTERONE; ANGIOTENSIN; ANGIOTENSIN II [1 SARCOSINE 8 ISOLEUCINE]; ANGIOTENSIN II [3-8]; ANGIOTENSIN III; ANGIOTENSIN RECEPTOR; ATRIAL NATRIURETIC FACTOR; BICARBONATE; BRADYKININ; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPEPTIDYL PEPTIDASE; INDOMETACIN; LISINOPRIL; MEMBRANE METALLOENDOPEPTIDASE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PHOSPHOLIPASE C; PHOSPHOLIPASE D; PROLINE CARBOXYPEPTIDASE; PROLYL ENDOPEPTIDASE; PROSTAGLANDIN; PROSTANOID; RENIN; SIGNAL PEPTIDE; SODIUM; UNINDEXED DRUG; VASOPRESSIN; WATER;

CONFERENCE PAPER; FEEDBACK SYSTEM; GENE; HUMAN; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FUNCTION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYNTHESIS; VASCULAR ENDOTHELIUM; VASODILATATION;

ANGIOTENSIN II; ANIMALS; ENDOTHELIUM, VASCULAR; HUMANS; KIDNEY; MUSCLE, SMOOTH, VASCULAR; PEPTIDE FRAGMENTS; VASODILATOR AGENTS;

EID: 0030810845     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/01.HYP.30.3.535     Document Type: Article

References (63)

1. Ferrario CM, Brosnihan KB. Angiotensin formation and degradation. In: Izzo JL Jr, Black HR, eds. Hypertension Primer. Dallas, Tex: American Heart Association; 1993: chap 9:17.
2. Ackerly JA, Felger TS, Peach MJ. Des-Asp1-angiotensin I: a metabolite of angiotensin I in the perfused feline adrenal. Eur J Pharmacol. 1976;38:113-121.
3. Swanson GN, Hanesworth JM, Sardinia MF, Coleman JKM, Wright JW, Hall KL, Miller-Wing AV, Stobb JW, Cook VI, Harding EC, Harding JW. Discovery of a distinct binding site for angiotensin II (3-8) a putative angiotensin IV receptor. Regul Pept. 1992;40:409-419.
4. Schiavone MT, Santos RAS, Brosnihan KB, Khosla MC, Ferrario CM. Release of vasopressin from the rat hypothalamo-neurohypophysial system by angiotensin-(1-7) heptapeptide. Proc Natl Acad Sci U S A. 1988;85:4095-4098.
5. Campagnole-Santos MJ, Diz DI, Santos RAS, Khosla MC, Brosnihan KB, Ferrario CM. Cardiovascular actions of angiotensin-(1-7) microinjected into the dorsomedial medulla of rats. Am J Physiol. 1989;257:H324-H329.
6. Ferrario CM, Brosnihan KB, Diz DI, Jaiswal N, Khosla MC, Milsted A, Tallant EA. Angiotensin-(1-7): a new hormone of the angiotensin system. Hypertension. 1991;18(suppl III):III-126-III-133.
7. Ferrario CM. Biological roles of angiotensin-(1-7). Hypertens Res. 1992;15:61-66.
8. Ferrario CM, Brosnihan KB. Angiotensin formation and degradation. In: Izzo JL Jr, Black HR, eds. Hypertension Primer. Dallas, Tex: American Heart Association; 1993: chap 9:17.
9. Chappell MC, Tallant EA, Brosnihan KB, Ferrario CM. Conversion of angiotensin I to angiotensin-(1-7) by thimet oligopeptidase (EC 3.4.24.15) in vascular smooth muscle cells. J Vasc Med Biol. 1994;5:129-137.
10. Ferrario CM, Chappell MC. A new myocardial conversion of angiotensin I. Curr Opin Cardiol. 1994;9:520-526.
11. Ferrario CM, Chappell MC, Tallant EA. Divergent pathways in the formation and function of the angiotensin system. Receptors in Cardiovascular Disease, III. Whitehouse Station, NJ: Merck & Co, Inc. Vol. 3(1);1996:5-12.
12. Welches WR, Brosnihan KB, Ferrario CM. A comparison of the properties, and enzymatic activity of three angiotensin processing enzymes: angiotensin converting enzyme, prolyl endopeptidase and neutral endopeptidase 24.11. Life Sci. 1993;52:1461-1480.
13. Ferrario CM, Barnes KL, Block CH, Brosnihan KB, Diz DI, Khosla MC, Santos RAS. Pathways of angiotensin formation and function in the brain. Hypertension. 1990;15(suppl I):I-13-I-19.
14. Welches WR, Santos RAS, Chappell MC, Brosnihan KB, Greene LJ, Ferrario CM. Evidence that prolyl endopeptidase participates in the processing of brain angiotensin. J Hypertens. 1991;9:631-638.
15. Chappell MC, Tallant EA, Brosnihan KB, Ferrario CM. Processing of angiotensin peptides by NG108-15 neuroblastoma x glioma hybrid cell line. Peptides. 1990;11:375-380.
16. Santos RAS, Brosnihan KB, Jacobsen DW, DiCorleto PE, Ferrario CM. Production of angiotensin-(1-7) by human vascular endothelium. Hypertension. 1992;19(suppl II):II-56-II-61.
17. Campbell DJ, Lawrence AC, Towrie A, Kladis A, Valentijn AJ. Differential regulation of angiotensin peptide levels in plasma and kidney of the rat. Hypertension. 1991;18:763-773.
18. Kohara K, Brosnihan KB, Chappell MC, Khosla MC, Ferrario CM. Angiotensin-(1-7): a member of circulating angiotensin peptides. Hypertension. 1991;17:131-138.
19. Kohara K, Brosnihan KB, Ferrario CM. Angiotensin-(1-7) in the spontaneously hypertensive rat. Peptides. 1993;14:883-891.
20. Luque M, Martin P, Martell N, Fernandez C, Brosnihan KB, Ferrario CM. Effects of captopril related to increased levels of prostacyclin and angiotensin-(1-7) in essential hypertension. J Hypertens. 1996;14:799-805.
21. Moriguchi A, Brosnihan KB, Kumagai H, Ganten D, Ferrario CM. Mechanisms of hypertension in transgenic rats expressing the mouse Ren-2 gene. Am J Physiol. 1994;266:R1273-R1278.
22. Campbell DJ, Kladis A, Duncan AM. Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides. Hypertension. 1994;23:439-449.
23. Koida M, Walter R. Post-proline cleaving enzyme. J Biol Chem. 1976;251:7593-7599.
24. Kumamoto K, Stewart TA, Johnson AR, Erdos KG. Prolylcarboxypeptidase (angiotensinase C) in human lung and cultured cells. J Clin Invest. 1981;67:210-215.
25. Nomura N, Shimamoto K, Ura N, Iwata M, Aoyama T, Takagawa Y, Iimura O. The role of kinins and atrial natriuretic peptide on the renal effects of neutral endopeptidase inhibitor in normotensive and hypertensive rats. Clin Exp Hypertens. 1995;17:1219-1231.
26. Jaiswal N, Tallant EA, Diz DI, Khosla MC, Ferrario CM. Subtype 2 angiotensin receptors mediate prostaglandin synthesis in human astrocytes. Hypertension. 1991;17:1115-1120.
27. Jaiswal N, Diz DI, Tallant EA, Khosla MC, Ferrario CM. Characterization of angiotensin receptors mediating prostaglandin synthesis in C6 glioma cells. Am J Physiol. 1991;260:R1000-R1006.
28. Jaiswal N, Diz DI, Chappell MC, Khosla MC, Ferrario CM. Stimulation of endothelial cell prostaglandin production by angiotensin peptides: characterization of receptors. Hypertension. 1992;19(suppl II):II-49-II-55.
29. Jaiswal N, Tallant EA, Jaiswal RK, Diz DI, Ferrario CM. Differential regulation of prostaglandin synthesis by angiotensin peptides in porcine aortic smooth muscle cells: subtypes of angiotensin receptors involved. J Pharmacol Exp Ther. 1993;265:664-673.
30. Tallant EA, Jaiswal N, Diz DI, Ferrario CM. Human astrocytes contain two distinct angiotensin receptor subtypes. Hypertension. 1991;18:32-39.
31. Benter IF, Diz DI, Ferrario CM. Cardiovascular actions of angiotensin-(1-7). Peptides. 1993;14:679-684.
32. Porsti I, Bara AT, Busse R, Hecker M. Release of nitric oxide by angiotensin-(1-7) from porcine coronary endothelium: implications for a novel angiotensin receptor. Br J Pharmacol. 1994;111:652-654.
33. Brosnihan KB, Li P, Ferrario CM. Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide. Hypertension. 1996;27:523-528.
34. Meng W, Busija DW. Comparative effects of angiotensin-(1-7) and angiotensin II on piglet pial arterioles. Stroke. 1993;24:2041-2045.
35. Osei SY, Ahima RS, Minkes RK, Weaver JP, Khosla MC, Kadowitz PJ. Differential responses to angiotensin-(1-7) in the feline mesenteric and hindquarters vascular beds. Eur J Pharmacol. 1993;234:35-42.
36. Campagnole-Santos MJ, Heringer SB, Batista EN, Khosla MC, Santos RAS. Differential baroreceptor reflex modulation by centrally infused angiotensin peptides. Am J Physiol. 1992;263:R89-R94.
37. Santos RAS, Campagnole-Santos MJ, Baracho NCV, Fontes MAP, Silva LCS, Neves LAA, Oliveira DR, Caligiorne SM, Rodrigues ARV, Gropen C Jr, Carvalho WS, Silva ASCE, Khosla MC. Characterization of a new angiotensin antagonist selective for angiotensin-(1-7): evidence that the actions of angiotensin-(1-7) are mediated by specific angiotensin receptors. Brain Res Bull. 1994;35:293-398.
38. Benter IF, Ferrario CM, Morris M, Diz DI. Antihypertensive actions of angiotensin-(1-7) in spontaneously hypertensive rats. Am J Physiol. 1995;269:H313-H319.
39. Benter IF, Diz DI, Ferrario CM. Pressor and reflex sensitivity is altered in spontaneously hypertensive rats treated with angiotensin-(1-7). Hypertension. 1995;26:1138-1144.
40. Moriguchi A, Tallant EA, Matsumura K, Reilly TM, Walton H, Ganten D, Ferrario CM. Opposing actions of angiotensin-(1-7) and angiotensin II in the brain of transgenic hypertensive rats. Hypertension. 1995;25:1260-1265.
41. Mahon JM, Carr RD, Nicol AK, Henderson IW. Angiotensin-(1-7) is an antagonist at the type 1 angiotensin II receptor. J Hypertens. 1994;12:1377-1381.
42. Tallant EA, Ganten D, Ferrario CM. Attenuated responses to angiotensin II in vascular smooth muscle cells from transgenic (mREN2)27 rats. J Hypertens. 1994;12:S178.
43. Nakamoto H, Ferrario CM, Fuller SB, Robaczwski DL, Winicov E, Dean RH. Angiotensin-(1-7) and nitric oxide interaction in renovascular hypertension. Hypertension. 1995;25:796-802.
44. Paula RD, Lima CV, Khosla MC, Santos RAS. Angiotensin-(1-7) potentiates the hypotensive effect of bradykinin in conscious rats. Hypertension. 1995;26:1154-1159.
45. Li P, Chappell MC, Ferrario CM, Brosnihan KB. Angiotensin-(1-7) augments bradykinin-induced vasodilation by competing with ACE and releasing nitric oxide. Hypertension. 1997;29:394-400.
46. Jaiswal N, Jaiswal RK, Tallant EA, Diz DI, Ferrario CM. Alterations in prostaglandin production in spontaneously hypertensive rat smooth muscle cells. Hypertension. 1993;21:900-905.
47. Freeman EJ, Ferrario CM, Tallant EA. Angiotensins differentially activate phospholipase D in vascular smooth muscle cells from spontaneously hypertensive and Wistar-Kyoto rats. Am J Hypertens. 1995;8:1105-1111.
48. Freeman EJ, Chisolm GM, Ferrario CM, Tallant EA. Angiotensin-(1-7) inhibits vascular smooth muscle cell growth. Hypertension. 1996;28:104-108.
49. Tallant EA, Lu X, Weiss RB, Chappell MC, Ferrario CM. Bovine aortic endothelial cells contain an angiotensin-(1-7) receptor. Hypertension. 1997;29:388-392.
50. Szigethy EM, Barnes KL, Diz DI. Light microscopic localization of angiotensin II binding sites in canine medulla using high resolution autoradiography. Brain Res Bull. 1992;29:813-819.
51. Ichikawa I, Harris RC. Angiotensin actions in the kidney: renewed insight into the old hormone. Kidney Int. 1991;40:583-596.
52. DelliPizzi A, Hilchey SD, Bell-Quilley CP. Natriuretic actions of angiotensin-(1-7). Br J Pharmacol. 1994;111:1-3.
53. 2 release. Hypertension. 1995;25:1238-1244.
54. Handa RK, Ferrario CM, Strandhoy JW. Renal actions of angiotensin-(1-7): in vivo and in vitro studies. Am J Physiol. 1996;270:F141-F147.
55. Garcia NH, Garvin JL. Angiotensin 1-7 has a biphasic effect on fluid absorption in the proximal straight tubule. J Am Soc Nephrol. 1994;5:1133-1138.
56. Kono T, Taniguchi A, Imura H, Oseko F, Khosla MC. Pressor activity of angiotensin II-(2-7)-hexapeptide in man. Endocrinol Jpn. 1985;32:767-769.
57. Santos RAS, Baracho NCV. Angiotensin-(1-7) is a potent antidiuretic peptide in rats. Braz J Med Biol Res. 1992;25:651-654.
58. Santos RAS, Silva ACS, Magaldi AJ, Khosla MC, Ceasr KR, Passaglio KT, Baracho NCV. Evidence for a physiological role of angiotensin-(1-7) in the control of hydroelectrolyte balance. Hypertension. 1996;27:875-884.
59. Burnier M, Pechere-Bertschi A, Nussberger J, Waeber B, Brunner HR. Studies of the renal effects of angiotensin II receptor blockade: the confounding factor of acute water loading on the action of vasoactive systems. Am J Kidney Dis. 1995;26:108-115.
60. Andreatta-Van Leyen S, Romero MF, Khosla MC, Douglas JG. Modulation of phospholipase A2 activity and sodium transport by angiotensin-(1-7). Kidney Int. 1993;44:932-936.
61. Stephenson SL, Kenny AJ. Metabolism of neuropeptides. Biochem J. 1987;241:237-247.
62. Chappell MC, Diz DI, Ferrario CM. Urinary angiotensin-(1-7): influence of converting enzyme and neprilysin inhibition. Hypertension. 1995;26:542. Abstract.
63. Ferrario CM, Martell N, Pinillas C, Brosnihan KB, Chappell MC, Novikov S, Perez D, Flack JM, Luque M. Essential hypertension is associated with low urinary levels of angiotensin-(1-7). Hypertension. 1996;28:515. Abstract.